Peripheral Vascular Devices | Europe (Part 2) | 2017 | Market Analysis
The European market for PV devices continues to be a lucrative space for companies with new, premium-priced products, such as DCBs and next-generation aortic stent grafts. However, pricing pressures due to budgetary constraints and strong price competition are negatively affecting revenues, which will result in only modest expansion through 2025.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Europe across a 10-year period.